Development of 5-FU and Doxorubicin-Loaded Cationic Liposomes against Human Pancreatic Cancer: Implications for Tumor Vascular Targeting

By Kalra Ashish   Campbell Robert  

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2809-2817

Springer Publishing Company

Access to resources Recommend Favorite

Monoclonal antibody 2C5-mediated binding of liposomes to brain tumor cells in vitro and in subcutaneous tumor model in vivo

By Gupta Bhawna   Levchenko Tatiana S.   Mongayt Dmitry A.   Torchilin Vladimir P.  

Journal of Drug Targeting, Vol. 13, Iss. 6, 2005-07 ,pp. : 337-343

Informa Healthcare

Access to resources Recommend Favorite

Cellular Association and Cytotoxicity of Doxorubicin-Loaded Immunoliposomes Targeted via Fab' Fragments of an Anti-CD74 Antibody

By Lundberg B. B.   Griffiths G.   Hansen H. J.  

Drug Delivery, Vol. 14, Iss. 3, 2007-03 ,pp. : 171-175

Informa Healthcare

Access to resources Recommend Favorite

PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells

By Dai Wenbing   Yang Tingyuan   Wang Xueqing   Wang Jiancheng   Zhang Xuan   Zhang Qiang  

Journal of Drug Targeting, Vol. 18, Iss. 4, 2010-05 ,pp. : 254-263

Informa Healthcare

Access to resources Recommend Favorite

Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2

By Roth Patrik   Hammer Caroline   Piguet Anne-Christine   Ledermann Monika   Dufour Jean-François   Waelti Ernst  

Journal of Drug Targeting, Vol. 15, Iss. 9, 2007-11 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite